Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma.
Stikvoort A, van der Schans J, Sarkar S, Poels R, Ruiter R, Naik J, Yuan H, de Bruijn JD, van de Donk NWCJ, Zweegman S, Themeli M, Groen R, O'Dwyer M, Mutis T. Stikvoort A, et al. Among authors: van de donk nwcj, van der schans j. Hemasphere. 2021 Jun 12;5(7):e596. doi: 10.1097/HS9.0000000000000596. eCollection 2021 Jul. Hemasphere. 2021. PMID: 34131635 Free PMC article.
Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis.
Holthof LC, van der Schans JJ, Katsarou A, Poels R, Gelderloos AT, Drent E, van Hal-van Veen SE, Li F, Zweegman S, van de Donk NWCJ, Themeli M, Groen RWJ, Mutis T. Holthof LC, et al. Among authors: van de donk nwcj, van hal van veen se, van der schans jj. Clin Cancer Res. 2021 Jul 1;27(13):3793-3803. doi: 10.1158/1078-0432.CCR-20-2188. Epub 2021 Apr 21. Clin Cancer Res. 2021. PMID: 33883175
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138.
van der Schans JJ, Wang Z, van Arkel J, van Schaik T, Katsarou A, Ruiter R, Baardemans T, Yuan H, de Bruijn J, Zweegman S, van de Donk NWCJ, Groen RWJ, Themeli M, Mutis T. van der Schans JJ, et al. Among authors: van de donk nwcj, van schaik t, van arkel j. Clin Cancer Res. 2023 Oct 13;29(20):4219-4229. doi: 10.1158/1078-0432.CCR-23-0132. Clin Cancer Res. 2023. PMID: 37527004
High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting.
Sultanov M, Koot JAR, de Bock GH, Greuter MJW, Beltman JJ, de Fouw M, de Zeeuw J, Kabukye J, Stekelenburg J, van der Schans J. Sultanov M, et al. Among authors: van der schans j. PLoS One. 2024 Oct 23;19(10):e0312295. doi: 10.1371/journal.pone.0312295. eCollection 2024. PLoS One. 2024. PMID: 39441790 Free PMC article.
Comparing health-related quality of life and utility scores of patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis in Indonesia.
Rokhman MR, Wardhani Y, Partiningrum DL, Purwanto BD, Hidayati IR, Idha A, At Thobari J, Postma MJ, Boersma C, van der Schans J. Rokhman MR, et al. Among authors: van der schans j. Perit Dial Int. 2024 Oct 3:8968608241285969. doi: 10.1177/08968608241285969. Online ahead of print. Perit Dial Int. 2024. PMID: 39360486 Free article.
47 results